BridgeBio Pharma, Inc. (BBIO)
78.17
-1.37
(-1.72%)
USD |
NASDAQ |
Nov 12, 16:00
77.76
-0.41
(-0.52%)
After-Hours: 20:00
BridgeBio Pharma Market Cap : 15.32B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 15.32B |
| November 11, 2026 | 15.59B |
| November 10, 2026 | 15.42B |
| November 09, 2026 | 15.27B |
| November 06, 2026 | 14.56B |
| November 05, 2026 | 14.56B |
| November 04, 2026 | 15.27B |
| November 03, 2026 | 14.51B |
| November 02, 2026 | 14.70B |
| October 30, 2026 | 14.69B |
| October 29, 2026 | 13.86B |
| October 28, 2026 | 13.88B |
| October 27, 2026 | 13.60B |
| October 26, 2026 | 13.31B |
| October 23, 2026 | 13.39B |
| October 22, 2026 | 13.30B |
| October 21, 2026 | 13.23B |
| October 20, 2026 | 13.19B |
| October 19, 2026 | 13.27B |
| October 16, 2026 | 12.96B |
| October 15, 2026 | 13.11B |
| October 14, 2026 | 12.68B |
| October 13, 2026 | 12.36B |
| October 12, 2026 | 12.84B |
| October 09, 2026 | 12.76B |
| Date | Value |
|---|---|
| October 08, 2026 | 12.70B |
| October 07, 2026 | 12.99B |
| October 06, 2026 | 13.08B |
| October 05, 2026 | 12.92B |
| October 02, 2026 | 13.13B |
| October 01, 2026 | 13.07B |
| September 30, 2026 | 12.85B |
| September 29, 2026 | 12.88B |
| September 28, 2026 | 13.01B |
| September 25, 2026 | 12.80B |
| September 24, 2026 | 12.94B |
| September 23, 2026 | 12.83B |
| September 22, 2026 | 13.52B |
| September 21, 2026 | 13.00B |
| September 18, 2026 | 13.01B |
| September 17, 2026 | 13.14B |
| September 16, 2026 | 13.34B |
| September 15, 2026 | 13.36B |
| September 14, 2026 | 14.13B |
| September 11, 2026 | 14.15B |
| September 10, 2026 | 14.16B |
| September 09, 2026 | 14.86B |
| September 08, 2026 | 14.60B |
| September 04, 2026 | 14.62B |
| September 03, 2026 | 14.73B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Ionis Pharmaceuticals, Inc. | 4.545B |
| Pfizer Inc. | 164.33B |
| Cytokinetics, Inc. | 7.819B |
| Vertex Pharmaceuticals, Inc. | 137.57B |
Market Cap Related Metrics
| PS Ratio | 16.12 |
| Price | 78.17 |
| Earnings Yield | -3.89% |